NCT07817641Recruiting
Proton Therapy for Mediastinal Lymphoma (PROMLY)
Source: ClinicalTrials.gov · Last updated 14 Sept 2026
Brief summary (registry, in English)
The study aims to investigate whether proton therapy is feasible in a national setting and whether proton therapy can reduce the risk of late toxicity (secondary cancers and heart toxicity) compared to foton therapy.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 139 (estimated)
- First submitted
- 30 Jul 2026
- Start date
- May 2026
- Primary completion date
- May 2046
- Lead sponsor
- Copenhagen University Hospital, Rigshospitalet
- NCT number
- NCT07817641
What you commit to
- Study type: Interventional
- Planned participants: 139
- From May 2026 to the primary completion date, May 2046
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Prior radiotherapy to the thorax
- Inability to attend full course of radiotherapy or follow-up visits in the outpatient clinic.
Other illness
- Other current malignancy
Who the study is looking for
- Patients 18 years or older
- Histologically proven Hodgkin or non-Hodgkin lymphoma
- Disease constrained within the mediastinum +/- neck and/or axilla involvement.
- Candidates for curative intended treatment
- Signed written informed consent.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Dept. of oncology Coordinator of this site? Confirm its status | Copenhagen | Denmark | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.